← FDA Drug Approvals (Drugs@FDA)

VEGZELMA

BLA · Biologics License Application · Sponsor: CELLTRION · Approved 2022-09-27

Drug application

FDA Application #

BLA761268

Application type

Biologics License Application

Brand name

VEGZELMA

Generic name

BEVACIZUMAB-ADCD

Active ingredients

BEVACIZUMAB-ADCD

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

CELLTRION

Manufacturer

CELLTRION USA, Inc.

First approval

2022-09-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown